Profiles of HCV core protein and viremia in chronic hepatitis C: Possible protective role of core antigen in liver damage

被引:14
|
作者
Carabaich, A [1 ]
Ruvoletto, M [1 ]
Bernardinello, E [1 ]
Tono, N [1 ]
Cavalletto, L [1 ]
Chemello, L [1 ]
Gatta, A [1 ]
Pontisso, P [1 ]
机构
[1] Univ Padua, Dipartimento Med Clin & Sperimentale, Clin Med 5, I-35123 Padua, Italy
关键词
nucleocapsid particles; liver disease activity; density gradient analysis; lipid associated HCV particles;
D O I
10.1002/jmv.20322
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The relation between HCV core antigen and HCV RNA has been confirmed in patients with chronic hepatitis C and a parallel behavior of the two markers has been described in early kinetics analysis during antiviral therapy. Variations of the core antigen to HCV RNA ratio have been reported in individual patients and the existence of nucleocapsid particles, not always associated with viral genomes, have been described. To assess the characteristics of HCV core antigen reactivity in relation to viremia in patients with different clinical profiles, 233 patients with chronic hepatitis C were studied serially. Group A included 54 asymptornatic HCV carriers, group B included 8 viremic patients with biochemical long-term response after antiviral therapy, while group C was composed of 171 patients with chronic liver disease and 75 were treated with combination therapy. Core antigen levels were not significantly different in the three groups of patients and a wide range of antigenic reactivity was observed in individual patients. A close relationship was observed between core antigen and HCV RNA, although their ratio was significantly higher in biochemical long-term responders (group 13), compared to the other groups (P < 0.05). Physicochemical characterization of core antigen reactivity by equilibrium CsCl density gradient identified two distinct peaks migrating at 1.08-1.12 g/ml CsCl density and at 1.18-1.31 CsCl density, respectively. The first one, corresponding to the lipid-associated fraction, contained higher amounts of core antigen reactivity and was associated with clinical remission of liver damage, while the second peak, corresponding to naked nucleocapsids, was observed mainly in sera with active disease. In conclusion, a close relationship between core and HCV RNA was documented both in treated and untreated patients. The finding of an excess of lipid-associated core particles in a subset of viremic patients without biochemical activity of liver disease suggests their protective effect in liver cell damage. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 50 条
  • [41] Sequence analysis of the hepatitis C virus (HCV) core gene suggests the core protein as an appropriate target for HCV vaccine strategies
    Hitomi, Y
    McDonnell, WM
    Killeen, AA
    Askari, FK
    JOURNAL OF VIRAL HEPATITIS, 1995, 2 (05) : 235 - 241
  • [42] Significance of IgM anti-HCV core level in chronic hepatitis C
    Papatheodoridis, GV
    Delladetsima, JK
    Katsoulidou, A
    Sypsa, V
    Albrecht, M
    Michel, G
    Hatzakis, A
    Tassopoulos, NC
    JOURNAL OF HEPATOLOGY, 1997, 27 (01) : 36 - 41
  • [43] The role in the hepatocarcinogenesis of antibody to hepatitis B core antigen in patients with HBsAg negative chronic liver disease
    Tanaka, H
    Iwasaki, Y
    Kobayashi, Y
    Nakamura, S
    Toshikuni, N
    Matsumoto, E
    Miyake, Y
    Ohnishi, H
    Sakaguchi, K
    Shiratori, Y
    Nouso, K
    GASTROENTEROLOGY, 2004, 126 (04) : A493 - A493
  • [44] Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C
    Chevaliez, Stephane
    Soulier, Alexandre
    Poiteau, Lila
    Bouvier-Alias, Magali
    Pawlotsky, Jean-Michel
    JOURNAL OF CLINICAL VIROLOGY, 2014, 61 (01) : 145 - 148
  • [45] Relationship between cryoglobulins and hepatitis C virus (HCV) core antigen or antibody titers
    Nagai, T
    Nagai, T
    Okazaki, T
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (01) : 105 - 106
  • [46] Comparison of a hepatitis C core antigen assay to nucleic acid amplification testing for detection of hepatitis C viremia in a US population
    Gunsolus, Ian L.
    Prostko, John
    Pearce, Sandra
    Degaga, Biniam
    Eickstead, Scott
    Taylor, Russ
    Grieshaber, Jessica
    Richard, Kyle
    Hoffman, Anne
    Pekalska, Aneta
    Daghfal, David
    MICROBIOLOGY SPECTRUM, 2024, 12 (11):
  • [47] HCV RNA AND ANTIBODY TO HCV CORE PROTEIN IN JAPANESE PATIENTS WITH CHRONIC LIVER-DISEASE
    YUKI, N
    HAYASHI, N
    HAGIWARA, H
    TAKEHARA, T
    KASAHARA, A
    FUSAMOTO, H
    MANABE, S
    TAKAMIZAWA, A
    KAMADA, T
    OKAYAMA, H
    DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (10) : 1483 - 1488
  • [48] Role of hepatitis C virus core antigen in HIV-HCV co-infected and chronic kidney disease patients on hemodialysis: expanding the HCV horizon of diagnostics
    Gupta, Ekta
    Kumbhar, Nitin
    Ramachandran, Krithiga
    Kumar, Guresh
    Kumar, Manoj
    Mathur, Rajendra Prasad
    JOURNAL OF HEPATOLOGY, 2020, 73 : S836 - S837
  • [49] Role of hepatitis B core-related antigen and antibodies to hepatitis B core antigen levels in the natural history of chronic HBV infection
    Caviglia, G. P.
    Olivero, A.
    Ciancio, A.
    Tandoi, F.
    Troshina, G.
    Bosco, C.
    Boglione, L.
    Rizzetto, M.
    Romagnoli, R.
    Saracco, G. M.
    Smedile, A.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 12 - 12
  • [50] Role of hepatitis B core-related antigen and antibodies to hepatitis B core antigen level in the natural history of chronic HBV infection
    Caviglia, G. P.
    Olivero, A.
    Ciancio, A.
    Tandoi, F.
    Troshina, G.
    Bosco, C.
    Boglione, L.
    Rizzetto, M.
    Romagnoli, R.
    Saracco, G. M.
    Smedile, A.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S483 - S483